Development of a novel bispecific antibody therapy to overcome myeloma heterogeneity

by Ehime UniversityMicrograph of a plasmacytoma, the histologic correlate of multiple myeloma. H&E stain. Credit: Wikipedia/CC BY-SA 3.0Multiple myeloma is still an incurable hematological ma

Updated on: March 25,2024

Development of a novel bispecific antibody therapy to overcome myeloma heterogeneity

by Ehime UniversityMicrograph of a plasmacytoma, the histologic correlate of multiple myeloma. H&E stain. Credit: Wikipedia/CC BY-SA 3.0Multiple myeloma is still an incurable hematological ma

Updated on:March 25,2024

Neuro-oncology experts reveal how to use AI to improve brain cancer diagnosis, monitoring and treatment

byIndiana UniversityIU School of Medicine's Spyridon Bakas said the new recommendations are a much-needed update to the current standard of care in which individual radiologists measure tumo

Updated on: December 01,2024

Neuro-oncology experts reveal how to use AI to improve brain cancer diagnosis, monitoring and treatment

byIndiana UniversityIU School of Medicine's Spyridon Bakas said the new recommendations are a much-needed update to the current standard of care in which individual radiologists measure tumo

Updated on:December 01,2024

Tailored online personal health record cancer tool increases survivor adherence to national guidelines

byRegenstrief InstituteScreenshot of personal health record, “My Follow-up Care” Dashboard. CEA: carcinoembryonic antigen; CT: computed tomography. Credit:JMIR Cancer(2022). DOI: 10.

Updated on: December 28,2023

Tailored online personal health record cancer tool increases survivor adherence to national guidelines

byRegenstrief InstituteScreenshot of personal health record, “My Follow-up Care” Dashboard. CEA: carcinoembryonic antigen; CT: computed tomography. Credit:JMIR Cancer(2022). DOI: 10.

Updated on:December 28,2023

New bladder cancer classification predicts treatment response

byCedars-Sinai Medical CenterStudy design and gene signatures of patients with high-risk NMIBC according to BCG response subtypes (BRS). Credit:Science Translational Medicine(2023).

Updated on: January 11,2024

New bladder cancer classification predicts treatment response

byCedars-Sinai Medical CenterStudy design and gene signatures of patients with high-risk NMIBC according to BCG response subtypes (BRS). Credit:Science Translational Medicine(2023).

Updated on:January 11,2024

Bladder cancer treatment can be better targeted and more effective, trials show

by European Association of UrologyCredit: Unsplash/CC0 Public DomainTesting for tumor DNA in the blood can successfully identify advanced bladder cancer patients who will not relapse following su

Updated on: April 06,2024

Bladder cancer treatment can be better targeted and more effective, trials show

by European Association of UrologyCredit: Unsplash/CC0 Public DomainTesting for tumor DNA in the blood can successfully identify advanced bladder cancer patients who will not relapse following su

Updated on:April 06,2024

Experimental AI method boosts doctors' ability to diagnose cancers and precancers of the esophagus

by Delthia Ricks , Medical XpressEndoscopic photographs of lesions in three false-negative patients. Credit:Science Translational Medicine(2024). DOI: 10.1126/scitranslmed.adk5395Artificia

Updated on: August 27,2024

Experimental AI method boosts doctors' ability to diagnose cancers and precancers of the esophagus

by Delthia Ricks , Medical XpressEndoscopic photographs of lesions in three false-negative patients. Credit:Science Translational Medicine(2024). DOI: 10.1126/scitranslmed.adk5395Artificia

Updated on:August 27,2024

Latest results from clinical trial show patients with advanced HER2-positive breast cancer live longer on pyrotinib

by Associação Advanced Breast Cancer Global AllianceCredit: Unsplash/CC0 Public DomainPatients with HER2-positive breast cancer that has started to spread to other parts of the body survive for longer

Updated on: April 18,2024

Latest results from clinical trial show patients with advanced HER2-positive breast cancer live longer on pyrotinib

by Associação Advanced Breast Cancer Global AllianceCredit: Unsplash/CC0 Public DomainPatients with HER2-positive breast cancer that has started to spread to other parts of the body survive for longer

Updated on:April 18,2024

Researchers discover potential new melanoma treatment, giving hope to patients

by Hunter Medical Research InstituteTumor response, PFS, and OS. A, Spider plot of tumor burden change of target lesions in reference to the baseline tumor burden in 18 patients with measurable t

Updated on: January 30,2024

Researchers discover potential new melanoma treatment, giving hope to patients

by Hunter Medical Research InstituteTumor response, PFS, and OS. A, Spider plot of tumor burden change of target lesions in reference to the baseline tumor burden in 18 patients with measurable t

Updated on:January 30,2024

Researchers gain new insights into chromosome shortening and identify new potential cancer drug targets

by Institute of Cancer ResearchALT-reliant cells, with telomeres being marked by the green dots. Credit: Cancer and Genome Stability Team at the ICRA new study has provided insights into an impor

Updated on: January 28,2024

Researchers gain new insights into chromosome shortening and identify new potential cancer drug targets

by Institute of Cancer ResearchALT-reliant cells, with telomeres being marked by the green dots. Credit: Cancer and Genome Stability Team at the ICRA new study has provided insights into an impor

Updated on:January 28,2024

Examining a potential second generation epigenetic therapy for advanced solid tumors

by Vall d'Hebron Institute of OncologyCredit: Unsplash/CC0 Public DomainPreliminary results of a first-in-human study show manageable toxicity and preliminary antitumor activity of a potential sec

Updated on: February 18,2024

Examining a potential second generation epigenetic therapy for advanced solid tumors

by Vall d'Hebron Institute of OncologyCredit: Unsplash/CC0 Public DomainPreliminary results of a first-in-human study show manageable toxicity and preliminary antitumor activity of a potential sec

Updated on:February 18,2024

Researchers identify lethal molecular alterations after current therapies fail patients with metastatic melanoma

by University of California, Los AngelesCredit: Pixabay/CC0 Public DomainIn a new translational study from UCLA Jonsson Comprehensive Cancer Center, researchers analyzed genetic changes in the or

Updated on: January 30,2024

Researchers identify lethal molecular alterations after current therapies fail patients with metastatic melanoma

by University of California, Los AngelesCredit: Pixabay/CC0 Public DomainIn a new translational study from UCLA Jonsson Comprehensive Cancer Center, researchers analyzed genetic changes in the or

Updated on:January 30,2024

Radiation oncology workforce expected to remain stable through 2030

by American Society for Radiation OncologyRadiation oncology total residency slot quotas 2010 - 2022. Credit:International Journal of Radiation Oncology*Biology*Physics(2023). DOI: 10

Updated on: January 30,2024

Radiation oncology workforce expected to remain stable through 2030

by American Society for Radiation OncologyRadiation oncology total residency slot quotas 2010 - 2022. Credit:International Journal of Radiation Oncology*Biology*Physics(2023). DOI: 10

Updated on:January 30,2024